Last reviewed: June 6, 2026
Last updated: June 6, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide dosing confusion often stems from the difference between milligrams and milliliters—two measurements that are not interchangeable. Understanding how 1.7 mg translates to ml depends entirely on your medication's concentration, which PlexusDx compounding partners clearly label on every vial.
Converting 1.7 mg Semaglutide to Milliliters: The Concentration Factor
The relationship between milligrams and milliliters is not universal. Milligrams measure the amount of active drug, while milliliters measure liquid volume. A 1.7 mg dose can occupy different volumes depending on whether your semaglutide is concentrated at 2.4 mg/ml, 5 mg/ml, or another strength. Most compounded semaglutide formulations used for weight loss fall into standard concentrations that your prescriber and pharmacy will specify.
If your compounded semaglutide contains 2.4 mg per ml, then 1.7 mg would require approximately 0.71 ml. If the concentration is 5 mg/ml, the same 1.7 mg dose would be roughly 0.34 ml. Your prescription label will always state the concentration, making calculation straightforward. PlexusDx compounding partners ensure this information is clearly printed so patients can measure accurately using the supplied insulin pen or syringe.
Never assume milliliter amounts based on another person's prescription. Concentration varies by formulation, and using the wrong volume creates serious dosing errors. Always reference your specific vial's concentration label before drawing any dose.
Standard Semaglutide Concentrations in Compounded Formulations
Licensed 503A compounding pharmacies prepare semaglutide at several standard concentrations to meet different patient needs and injection preferences. Common concentrations include 2.4 mg/ml, 3 mg/ml, and 5 mg/ml solutions. Practitioners select the concentration based on your target dose range and whether you prefer smaller or larger injection volumes.
A 1.7 mg dose on a 2.4 mg/ml preparation is a typical intermediate step in many weight loss protocols. This concentration balances ease of injection with precise dose delivery. Patients using PlexusDx Compounded Semaglutide Injection receive detailed instructions specific to their vial's concentration, eliminating guesswork and ensuring safety.
Semaglutide Dosing Protocols: How 1.7 mg Fits Your Weight Loss Journey
Most semaglutide weight loss programs begin at 0.25 mg weekly, then gradually increase by 0.25 mg increments every 4 weeks. A 1.7 mg dose typically appears 4–6 months into treatment as patients reach higher therapeutic levels. This gradual escalation allows your body to adapt while minimizing gastrointestinal side effects like nausea and constipation.
Your dose may need to go up, but your price won't—PlexusDx charges a flat monthly rate starting at $149/month for Compounded Semaglutide Injection regardless of dose adjustments. This pricing model removes the financial barrier that can discourage patients from reaching their optimal therapeutic dose. The goal is to find the lowest effective dose that produces meaningful weight loss while maintaining tolerability.
Some patients reach their target weight at 1.0 mg weekly, while others require 2.0 mg or the maximum 2.4 mg dose. Your prescriber will assess your progress every 4 weeks and adjust accordingly. The 1.7 mg dose is not a fixed endpoint but a waypoint that many patients pass through on the path to their personalized therapeutic dose.
Precision Peptide Genetic Testing: Optimizing Your Semaglutide Response
Not every patient responds identically to semaglutide at the same dose. Genetic variations in the GLP-1 receptor, GIPR pathway, and metabolic genes significantly influence how effectively your body uses this medication. PlexusDx Precision Peptide Genetic Test analyzes key variants including GLP1R rs6923761, GIPR rs1800437, and FTO rs9939609 to predict your peptide-pathway responsiveness.
Understanding your genetic profile helps your prescriber personalize your starting dose, escalation schedule, and target maintenance level. Patients with certain genetic markers may reach optimal weight loss at lower doses like 1.0 mg, while others benefit from higher doses. This test costs $99 as an add-on after your first month of treatment, offering clarity that can save months of trial-and-error dosing.
PlexusDx maps 14 metabolic pathways across 49 peptides and 150+ genetic insights, providing your practitioner with a comprehensive picture of how your body's chemistry interacts with GLP-1 medications. Combined with your clinical response at doses like 1.7 mg, this data enables truly personalized treatment.
Measuring and Injecting Your 1.7 mg Semaglutide Safely
Proper injection technique begins with accuracy in measurement. Most compounded semaglutide is delivered via an insulin pen or prefilled syringe. Before drawing your dose, verify the vial's concentration label matches your prescription. Clean the rubber stopper with an alcohol swab, let it dry completely, and insert the needle at a 90-degree angle.
Draw back the syringe plunger to create negative pressure, then inject air into the vial equivalent to your dose volume. This equalizes pressure and makes withdrawal smoother. Slowly pull back the plunger to draw your prescribed volume—for 1.7 mg on a 2.4 mg/ml concentration, that's approximately 0.71 ml. Hold the syringe at eye level to confirm the meniscus reaches your target line.
Inject subcutaneously into your abdomen, thigh, or upper arm at least 2 inches away from your navel and any bruises or scars. Rotate injection sites weekly to prevent lipohypertrophy (thickened tissue). Store your vial in the refrigerator between 36–46°F, and never freeze. Your PlexusDx compounding pharmacy provides detailed written instructions tailored to your specific preparation.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is 1.7 mg a standard semaglutide maintenance dose?
1.7 mg is a common intermediate dose in many weight loss protocols, typically reached 4–6 months into treatment. Some patients maintain at this level, while others continue to 2.0 mg or the maximum 2.4 mg weekly. Your prescriber will assess your weight loss progress and tolerability to determine if 1.7 mg is your optimal dose or if further adjustment is needed.
How do I calculate milliliters if my semaglutide concentration is different?
Divide your dose in milligrams by the concentration in mg/ml. For example, 1.7 mg ÷ 5 mg/ml = 0.34 ml. Always verify your vial's concentration on the label before calculating. PlexusDx compounding partners print this information clearly, and your pharmacy can confirm the math if you're uncertain.
Can I switch between different semaglutide concentrations mid-treatment?
Yes, but only under your prescriber's supervision. Switching concentrations requires recalculating your dose volume to maintain the same milligram amount. This change does not affect your PlexusDx flat monthly price of $149, so cost is not a barrier to finding the concentration that works best for your injection preference.
What are the side effects of reaching 1.7 mg semaglutide?
Common side effects at higher doses include nausea, constipation, and reduced appetite—which also drive the weight loss effect. Most side effects diminish within 1–2 weeks as your body adapts. Staying hydrated, eating smaller frequent meals, and increasing fiber intake help manage these effects. Contact your prescriber if side effects persist or become severe.
Does PlexusDx genetic testing predict how well I'll respond to 1.7 mg?
PlexusDx Precision Peptide Genetic Test identifies variations in your GLP-1 receptor and related metabolic pathways that influence medication responsiveness. Testing reveals whether you're a high, moderate, or lower responder to semaglutide, helping your prescriber predict whether 1.7 mg will be adequate or if a higher dose is necessary. The test costs $99 after your first month and can accelerate your path to optimal dosing.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How Long is an Ozempic Pen Good For Once Opened: A Comprehensive Guide to Maintaining Efficacy
Does Ozempic Help with Menopause? Understanding the Connection